Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases
Abstract The aim of the study was to clarify the effect of long-term anti-TNF therapy on T cell function in patients with rheumatologic immune-mediated inflammatory diseases (IMID). The production of IFNγ by T cells was evaluated at baseline and after 1, 2, 4, and 8 years of anti-TNF agents by means...
Saved in:
Main Authors: | Ilaria Sauzullo, Rossana Scrivo, Paola Sessa, Fabio Mengoni, Vincenzo Vullo, Guido Valesini, Claudio Maria Mastroianni |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/13142ffa8a0249babfe4de8ce5ecb69d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection.
by: Pasqua Gramegna, et al.
Published: (2011) -
Trivalent soluble TNF Receptor, a potent TNF-α antagonist for the treatment collagen-induced arthritis
by: Xiaofang Cui, et al.
Published: (2018) -
Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period.
by: Daouda Sissoko, et al.
Published: (2009) -
Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
by: Acar M, et al.
Published: (2018) - Rheumatic Fever & Rheumatic Heart Disease